Biotech Viking Therapeutics has gained prominence over the past two years, but it could have plenty of upside left.

India’s GLP-1 drug market is poised for explosive growth, outpacing global trends and positioning domestic pharma giants to challenge multinational dominance.

The top China executive of US pharmaceutical company Eli Lilly and Co said on Wednesday that the company aims to make its ...

Healthcare stocks can provide growth and consistent returns through a variety of market cycles. Eli Lilly has a storied ...

Walmart Pharmacies to offer weight-loss drug making obesity treatment more accessible for millions nationwide.

These growth stocks are highly profitable and evolving in their respective industries. Eli Lilly is famed for its weight-loss medications, but it is more than just a GLP-1 play. MercadoLibre is a ...

Though Novo Nordisk and Lilly already dominate the market, demand is so great for these products ... Eli Lilly It's ...

Novo Nordisk and Pfizer are showing some desperation in their gloves-off tussle for the obesity-drug assets of Metsera.

What's better than investing in a stock with a promising outlook? Investing in a beaten-down stock with a promising outlook.

Eli Lilly has once again delivered extraordinary financial results, powered by its highly successful diabetes and obesity treatments. The pharmaceutical giant's third-quarter performance has left ...

Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.

Nvidia Corp. (NVDA) hit $5 trillion this week. Yes, trillion—with a “T.” This isn’t hype. From AI chips to autonomous cars, ...